Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind study of adding metformin to SYR-322 in type 2 diabetes
jRCT2080222327Phase 3
- Sponsor
- Takeda
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing SYR-322 + metformin with SYR-322 control arm (2 arms).
02
Drugs
alogliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080222327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222327.